Expression of Nutrient Transporters in Placentas Affected by Gestational Diabetes: Role of Leptin
Overview
Authors
Affiliations
Gestational diabetes mellitus (GDM) is the most frequent pathophysiological state of pregnancy, which in many cases produces fetuses with macrosomia, requiring increased nutrient transport in the placenta. Recent studies by our group have demonstrated that leptin is a key hormone in placental physiology, and its expression is increased in placentas affected by GDM. However, the effect of leptin on placental nutrient transport, such as transport of glucose, amino acids, and lipids, is not fully understood. Thus, we aimed to review literature on the leptin effect involved in placental nutrient transport as well as activated leptin signaling pathways involved in the expression of placental transporters, which may contribute to an increase in placental nutrient transport in human pregnancies complicated by GDM. Leptin appears to be a relevant key hormone that regulates placental transport, and this regulation is altered in pathophysiological conditions such as gestational diabetes. Adaptations in the placental capacity to transport glucose, amino acids, and lipids may underlie both under- or overgrowth of the fetus when maternal nutrient and hormone levels are altered due to changes in maternal nutrition or metabolic disease. Implementing new strategies to modulate placental transport may improve maternal health and prove effective in normalizing fetal growth in cases of intrauterine growth restriction and fetal overgrowth. However, further studies are needed to confirm this hypothesis.
The Role of Purine Metabolism and Uric Acid in Postnatal Neurologic Development.
Mileti L, Baleja J Molecules. 2025; 30(4).
PMID: 40005150 PMC: 11858483. DOI: 10.3390/molecules30040839.
Zhu X, Wang W, Yang Y, Zhou H, Long W, Zhang B J Diabetes Metab Disord. 2024; 24(1):18.
PMID: 39712342 PMC: 11659532. DOI: 10.1007/s40200-024-01522-3.
Acquired Partial Lipodystrophy: Clinical Management in a Pregnant Patient.
Romanisio M, Bighetti L, Daffara T, Mollero E, Pelosini C, Antoniotti V J Endocr Soc. 2024; 8(12):bvae181.
PMID: 39479521 PMC: 11521335. DOI: 10.1210/jendso/bvae181.
Abid S, Abdulla T, Sadiq F Cureus. 2024; 16(7):e65020.
PMID: 39165468 PMC: 11335178. DOI: 10.7759/cureus.65020.
Implications of pregnancy on cardiometabolic disease risk: preeclampsia and gestational diabetes.
Elgazzaz M, Woodham P, Maher J, Faulkner J Am J Physiol Cell Physiol. 2024; 327(3):C646-C660.
PMID: 39010840 PMC: 11427017. DOI: 10.1152/ajpcell.00293.2024.